Your session is about to expire
← Back to Search
Other
Wild Rice Blends for Blood Sugar Control (EFGW Trial)
N/A
Waitlist Available
Led By Dylan MacKay, PHD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Male or female between 18-50 years old
Participant must receive at least two doses of COVID-19 vaccine that have been recognized by Winnipeg Regional Health Authorities.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up vas measurements at 0 (baseline) and then 15, 30, 45, 60, 90 and 120 minutes.
Awards & highlights
EFGW Trial Summary
This trial tests the effects of wild rice on glycemic control & response in healthy people, to see if it affects appetite & palatability. Participants attend 5 study visits & fast for 10-12 hours each visit.
Who is the study for?
This trial is for healthy adults aged 18-50 with normal fasting blood sugar and a BMI of 18.9-29.9 who eat breakfast regularly and are fully vaccinated against COVID-19. It's not for pregnant women, heavy drinkers, those with recent significant weight changes or surgery, rice allergies, restrictive diets like veganism or keto, or anyone on certain medications affecting carbohydrate metabolism.Check my eligibility
What is being tested?
The study tests how different types of rice—wild rice alone and blends with brown rice cooked via stovetop or microwave—affect blood sugar control in comparison to white and brown rice. Participants will attend five sessions where they'll fast beforehand and have their glycemic response measured after eating the rices.See study design
What are the potential side effects?
Since this trial involves consuming various types of rice which are common foods rather than drugs, there aren't typical side effects as seen in drug trials. However, participants may experience differences in appetite or personal taste preferences.
EFGW Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 50 years old.
Select...
I have received at least two COVID-19 vaccine doses approved by Winnipeg health authorities.
EFGW Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ capillary blood glucose will be measured at 0 (baseline) and then 15, 30, 45, 60, 90 and 120 minutes after the treatment has been consumed..
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~capillary blood glucose will be measured at 0 (baseline) and then 15, 30, 45, 60, 90 and 120 minutes after the treatment has been consumed..
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Glycemic response
Secondary outcome measures
Palatability of rice products
Subjective appetite
EFGW Trial Design
5Treatment groups
Experimental Treatment
Active Control
Group I: Consumption of 3 of 3 rice productsExperimental Treatment1 Intervention
This arm will provide the third consumption of the randomly assigned rice product. There will be a minimum of three days separating each visit.
Group II: Consumption of 2 of 3 rice productsExperimental Treatment1 Intervention
This arm will provide the consumption of the second randomly assigned rice product. There will be a minimum of three days separating each visit.
Group III: Consumption of 1 of 3 rice products with different preparation methodExperimental Treatment1 Intervention
This arm will provide the blends product via a different cooking method (microwave).
Group IV: Consumption of 1 of 3 rice productsExperimental Treatment1 Intervention
This arm will provide 1 of the 3 randomly assigned rice products to the participant and there will be a minimum of three days separating each visit.
Group V: Consumption of the control rice productActive Control1 Intervention
This arm will provide the white rice control product.
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,502 Total Patients Enrolled
MitacsIndustry Sponsor
38 Previous Clinical Trials
4,341 Total Patients Enrolled
Dylan MacKay, PHDPrincipal InvestigatorUniversity of Manitoba
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't taken drugs or supplements that affect blood sugar levels in the last 4 weeks.I have a history of significant health issues, including eating disorders, AIDS, hepatitis, diabetes, heart disease, lung problems, or GI disorders.I have a history of high blood pressure.You typically eat breakfast.I am not pregnant, breastfeeding, nor planning to become pregnant during the trial.I can complete study treatments in less than 10 minutes.I have not had any cancer except for non-melanoma skin cancer in the last two years.I have not had major surgery or significant physical trauma in the last 3 months.I am between 18 and 50 years old.I have received at least two COVID-19 vaccine doses approved by Winnipeg health authorities.You have had a bad reaction or allergy to rice before.You follow a special diet like vegan, low-carb, or keto.You have gained or lost more than 3.5kg of weight in the past 3 months.Your body mass index (BMI) falls within the range of 18.9 to 29.9 kg/m2.
Research Study Groups:
This trial has the following groups:- Group 1: Consumption of 2 of 3 rice products
- Group 2: Consumption of 3 of 3 rice products
- Group 3: Consumption of 1 of 3 rice products
- Group 4: Consumption of the control rice product
- Group 5: Consumption of 1 of 3 rice products with different preparation method
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the patient pool for this research project limited to individuals over 20 years old?
"As outlined in the trial's eligibility criteria, no patient below 18 years old or above 50 can be enrolled."
Answered by AI
Am I a suitable participant for this research project?
"To be considered for this medical investigation, applicants must have normal blood glucose levels and belong to the 18-50 age group. The researchers are looking to recruit a total of 20 individuals."
Answered by AI
Is this scientific research accepting new participants at the present?
"According to the available information on clinicaltrials.gov, this trial is still actively looking for participants. This study was initially posted on August 10th 2023 and its most recent update was made on August 3rd of the same year."
Answered by AI
What is the maximum enrolment capacity for this research project?
"Affirmative. Clinicaltrials.gov data suggests that this trial is actively recruiting for participants, having been initially announced on August 10th 2023 with the most recent update occurring a week later on August 3rd 2023. The study requires approximately twenty individuals to be enrolled at one site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger